FTSE 100
|
9 899,60
|
112,45
|
1,15 %
|
Analysen zu FTSE 100-Werten
| 03.01.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 03.01.24 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 03.01.24 | GSK Buy | Jefferies & Company Inc. | |
| 02.01.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 28.12.23 | Unilever Market-Perform | Bernstein Research | |
| 28.12.23 | Reckitt Benckiser Outperform | Bernstein Research | |
| 27.12.23 | GSK Equal Weight | Barclays Capital | |
| 27.12.23 | AstraZeneca Buy | UBS AG | |
| 22.12.23 | Rio Tinto Overweight | JP Morgan Chase & Co. | |
| 21.12.23 | easyJet Neutral | JP Morgan Chase & Co. | |
| 20.12.23 | Rio Tinto Sector Perform | RBC Capital Markets | |
| 20.12.23 | Diageo Outperform | Bernstein Research | |
| 20.12.23 | Vodafone Group Equal Weight | Barclays Capital | |
| 20.12.23 | Reckitt Benckiser Neutral | Goldman Sachs Group Inc. | |
| 20.12.23 | HSBC Holdings Sector Perform | RBC Capital Markets | |
| 19.12.23 | International Consolidated Airlines Neutral | UBS AG | |
| 19.12.23 | easyJet Buy | UBS AG | |
| 19.12.23 | Reckitt Benckiser Overweight | Barclays Capital | |
| 19.12.23 | Rio Tinto Neutral | UBS AG | |
| 19.12.23 | Vodafone Group Buy | Deutsche Bank AG | |
| 19.12.23 | GSK Buy | Deutsche Bank AG | |
| 18.12.23 | Reckitt Benckiser Underperform | Jefferies & Company Inc. | |
| 18.12.23 | Reckitt Benckiser Buy | UBS AG | |
| 18.12.23 | Vodafone Group Equal Weight | Barclays Capital | |
| 18.12.23 | Unilever Market-Perform | Bernstein Research | |
| 18.12.23 | Rolls-Royce Buy | Jefferies & Company Inc. | |
| 18.12.23 | Reckitt Benckiser Overweight | JP Morgan Chase & Co. | |
| 15.12.23 | AstraZeneca Hold | Deutsche Bank AG | |
| 15.12.23 | GSK Buy | Deutsche Bank AG | |
| 15.12.23 | Flutter Entertainment Buy | Jefferies & Company Inc. | |
| 15.12.23 | Unilever Underperform | Jefferies & Company Inc. | |
| 14.12.23 | Flutter Entertainment Neutral | JP Morgan Chase & Co. | |
| 14.12.23 | National Grid Overweight | JP Morgan Chase & Co. | |
| 13.12.23 | Rio Tinto Neutral | UBS AG | |
| 13.12.23 | Glencore Buy | UBS AG | |
| 13.12.23 | BP Buy | Goldman Sachs Group Inc. | |
| 13.12.23 | Shell Buy | Goldman Sachs Group Inc. | |
| 12.12.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 12.12.23 | AstraZeneca Buy | UBS AG | |
| 12.12.23 | BAT Sector Perform | RBC Capital Markets |